FMA Advisory’s Pfizer PFE Stock Holding History

FMA Advisory’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$2.71M	Buy	62,945 +2,582	+4%	+$114K	1.01%	34
2021 Q2	$2.36M	Buy	60,363 +1,345	+2%	+$52.3K	0.88%	44
2021 Q1	$2.14M	Buy	59,018 +1,024	+2%	+$36.4K	0.66%	56
2020 Q4	$2.13M	Sell	57,994 -4,783	-8%	-$175K	0.71%	48
2020 Q3	$2.19M	Buy	62,777 +4,438	+8%	+$156K	0.87%	40
2020 Q2	$1.81M	Buy	58,339 +1,642	+3%	+$55.8K	0.81%	42
2020 Q1	$1.76M	Buy	56,697 +3,016	+6%	+$103K	0.95%	38
2019 Q4	$2M	Buy	53,681 +5,474	+11%	+$195K	0.8%	46
2019 Q3	$1.64M	Sell	48,207 -2,616	-5%	-$95.1K	0.71%	49
2019 Q2	$2.09M	Sell	50,823 -202	-0.4%	-$8.02K	0.93%	42
2019 Q1	$2.06M	Sell	51,025 -796	-2%	-$31.9K	0.94%	40
2018 Q4	$2.15M	Buy	51,821 +452	+0.9%	+$18.8K	1.11%	28
2018 Q3	$2.15M	Buy	51,369 +208	+0.4%	+$8.01K	0.96%	39
2018 Q2	$1.76M	Buy	51,161 +284	+0.6%	+$9.71K	0.83%	47
2018 Q1	$1.71M	Buy	50,877 +517	+1%	+$17.8K	0.83%	44
2017 Q4	$1.73M	Buy	50,360 +2,975	+6%	+$101K	0.81%	43
2017 Q3	$1.6M	Sell	47,385 -207	-0.4%	-$6.65K	0.94%	38
2017 Q2	$1.52K	Sell	47,592 -1,481	-3%	-$46.7K	0.78%	39
2017 Q1	$1.59M	Buy	+49,073	New	+$1.55M	0.81%	44
2015 Q2	$179K	Buy	+5,624	New	+$183K	0.11%	119
2014 Q4	$518K	Sell	17,517 -3,174	-15%	-$91K	0.18%	119
2014 Q3	$580K	Sell	20,691 -1,976	-9%	-$55.5K	0.21%	113
2014 Q2	$638K	Buy	22,667 +1,389	+7%	+$39.6K	0.23%	108
2014 Q1	$648K	Buy	21,278 +295	+1%	+$8.8K	0.25%	108
2013 Q4	$610K	Buy	20,983 +43	+0.2%	+$1.25K	0.25%	104
2013 Q3	$571K	Buy	20,940 +253	+1%	+$6.88K	0.23%	116
2013 Q2	$550K	Buy	+20,687	New	+$572K	0.23%	115

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

FMA Advisory's PFE Position: Q3 2021 in Review

FMA Advisory increased its Pfizer (PFE) stake by 4.3% in Q3 2021, buying an estimated $114K and bringing the position to 62,945 shares worth $2.71M. The position accounts for 1.01% of the portfolio, ranked #34.

FMA Advisory first reported a position in PFE in Q2 2013 and has held it in 27 quarters since. 2,803 funds tracked by Wall St. Rank hold PFE as of Q3 2021.

FMA Advisory held 62,945 shares of Pfizer worth $2.71M as of Q3 2021.
FMA Advisory bought 2,582 Pfizer shares in Q3 2021, an estimated $114K.
Pfizer made up 1.01% of FMA Advisory's portfolio in Q3 2021, its #34 holding.
FMA Advisory first reported a position in Pfizer in Q2 2013 and has held it in 27 quarters since.
2,803 funds tracked by Wall St. Rank held Pfizer as of Q3 2021.

Based on FMA Advisory's 13F filing for Q3 2021, filed 15 Nov 2021.